VITAMIN D RECEPTOR GENE MUTATIONS AND VITAMIN D SERUM LEVELS IN ASTHMATIC CHILDREN
OBJECTIVE: To verify the relationship between polymorphisms of the vitamin D receptor gene (VDR), clinical findings, and serum vitamin D (VD) levels in asthmatics.
METHODS: A cross sectional study of 77 children aged 7 to 14 years old, who were attended at a specialized clinic. The children were divided into 3 groups: asthmatics who had been using inhaled corticosteroids (ICS) for more than one year; asthmatics who had not been using ICS; non-asthmatics, and children without allergies (according to the International Study of Asthma and Allergies in Childhood -- ISAAC). Spirometry, skin prick tests, the presence of a VDR promoter CDX2 polymorphism from an allele-specific polimerase chain reaction (PCR), exons 2 and 3 polymorphisms genotyping by PCR-SSCA (single-strand conformational analysis), total immunoglobulin E (IgE) and specific IgE to mites and grass were evaluated in these three groups. Levels of 25-hydroxyvitamin D were determined in asthmatics only.
RESULTS: The mean age of the children was 10.8±2.0 years old, 57% were male, 38 were asthmatic and using ICS, 22 were asthmatic and not using ICS, and 17 were non-asthmatic. Allergic rhinitis was present in 90% of asthmatics. Homozygous CDX2 was detected in 23% of the patients and absent in the control group (p=0.03). Lower forced expiratory volume in 1 second (FEV1%) values were observed in CDX2 homozygous asthmatics (p=0.001). Variations in the exon 2 and 3 sequences were not related to asthma or the other tests. VD deficiency or insufficiency was detected in 98% of asthmatics. There was no association between VD levels and genetic polymorphisms from exons 2 and 3.
CONCLUSIONS: There was a positive association between homozygous CDX2 polymorphism, asthma and lower FEV1% values. CDX2 is capable of modifying cell interaction between VDR and VD, and it could be associated with the prevalence of asthma, and the difficulty in controlling the disease.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2018 |
---|---|
Erschienen: |
2018 |
Enthalten in: |
Zur Gesamtaufnahme - volume:36 |
---|---|
Enthalten in: |
Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo - 36(2018), 3 vom: 26. Juli, Seite 269-274 |
Sprache: |
Portugiesisch |
---|
Weiterer Titel: |
MUTAÇÕES DO GENE DO RECEPTOR DE VITAMINA D E NÍVEIS SÉRICOS DE VITAMINA D EM CRIANÇAS COM ASMA |
---|
Beteiligte Personen: |
Santos, Hevertton Luiz Bozzo Silva [VerfasserIn] |
---|
Links: |
---|
Themen: |
1406-16-2 |
---|
Anmerkungen: |
Date Completed 16.05.2019 Date Revised 08.04.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1590/1984-0462/;2018;36;3;00016 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM287065502 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM287065502 | ||
003 | DE-627 | ||
005 | 20231225053158.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2018 xx |||||o 00| ||por c | ||
024 | 7 | |a 10.1590/1984-0462/;2018;36;3;00016 |2 doi | |
028 | 5 | 2 | |a pubmed24n0956.xml |
035 | |a (DE-627)NLM287065502 | ||
035 | |a (NLM)30066819 | ||
035 | |a (PII)S0103-05822018000300269 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a por | ||
100 | 1 | |a Santos, Hevertton Luiz Bozzo Silva |e verfasserin |4 aut | |
245 | 1 | 0 | |a VITAMIN D RECEPTOR GENE MUTATIONS AND VITAMIN D SERUM LEVELS IN ASTHMATIC CHILDREN |
246 | 3 | 3 | |a MUTAÇÕES DO GENE DO RECEPTOR DE VITAMINA D E NÍVEIS SÉRICOS DE VITAMINA D EM CRIANÇAS COM ASMA |
264 | 1 | |c 2018 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 16.05.2019 | ||
500 | |a Date Revised 08.04.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a OBJECTIVE: To verify the relationship between polymorphisms of the vitamin D receptor gene (VDR), clinical findings, and serum vitamin D (VD) levels in asthmatics | ||
520 | |a METHODS: A cross sectional study of 77 children aged 7 to 14 years old, who were attended at a specialized clinic. The children were divided into 3 groups: asthmatics who had been using inhaled corticosteroids (ICS) for more than one year; asthmatics who had not been using ICS; non-asthmatics, and children without allergies (according to the International Study of Asthma and Allergies in Childhood -- ISAAC). Spirometry, skin prick tests, the presence of a VDR promoter CDX2 polymorphism from an allele-specific polimerase chain reaction (PCR), exons 2 and 3 polymorphisms genotyping by PCR-SSCA (single-strand conformational analysis), total immunoglobulin E (IgE) and specific IgE to mites and grass were evaluated in these three groups. Levels of 25-hydroxyvitamin D were determined in asthmatics only | ||
520 | |a RESULTS: The mean age of the children was 10.8±2.0 years old, 57% were male, 38 were asthmatic and using ICS, 22 were asthmatic and not using ICS, and 17 were non-asthmatic. Allergic rhinitis was present in 90% of asthmatics. Homozygous CDX2 was detected in 23% of the patients and absent in the control group (p=0.03). Lower forced expiratory volume in 1 second (FEV1%) values were observed in CDX2 homozygous asthmatics (p=0.001). Variations in the exon 2 and 3 sequences were not related to asthma or the other tests. VD deficiency or insufficiency was detected in 98% of asthmatics. There was no association between VD levels and genetic polymorphisms from exons 2 and 3 | ||
520 | |a CONCLUSIONS: There was a positive association between homozygous CDX2 polymorphism, asthma and lower FEV1% values. CDX2 is capable of modifying cell interaction between VDR and VD, and it could be associated with the prevalence of asthma, and the difficulty in controlling the disease | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Observational Study | |
650 | 7 | |a Adrenal Cortex Hormones |2 NLM | |
650 | 7 | |a Receptors, Calcitriol |2 NLM | |
650 | 7 | |a VDR protein, human |2 NLM | |
650 | 7 | |a Vitamin D |2 NLM | |
650 | 7 | |a 1406-16-2 |2 NLM | |
650 | 7 | |a Calcium |2 NLM | |
650 | 7 | |a SY7Q814VUP |2 NLM | |
700 | 1 | |a Silva, Silvia de Souza E |e verfasserin |4 aut | |
700 | 1 | |a Paula, Estela de |e verfasserin |4 aut | |
700 | 1 | |a Pereira-Ferrari, Lilian |e verfasserin |4 aut | |
700 | 1 | |a Mikami, Liya |e verfasserin |4 aut | |
700 | 1 | |a Riedi, Carlos Antônio |e verfasserin |4 aut | |
700 | 1 | |a Chong-Neto, Herberto José |e verfasserin |4 aut | |
700 | 1 | |a Rosário, Nelson Augusto |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo |d 1997 |g 36(2018), 3 vom: 26. Juli, Seite 269-274 |w (DE-627)NLM090654293 |x 1984-0462 |7 nnns |
773 | 1 | 8 | |g volume:36 |g year:2018 |g number:3 |g day:26 |g month:07 |g pages:269-274 |
856 | 4 | 0 | |u http://dx.doi.org/10.1590/1984-0462/;2018;36;3;00016 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 36 |j 2018 |e 3 |b 26 |c 07 |h 269-274 |